- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.11. | Vasomedical reports Q3 results | 1 | Seeking Alpha | ||
| VASO Aktie jetzt für 0€ handeln | |||||
| 14.11. | Vaso Corporation Announces Financial Results for Third Quarter 2024 | 43 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading medtech company with a diversified business portfolio in network and healthcare IT services, professional... ► Artikel lesen | |
| 19.09. | Vaso announces termination of business combination with Achari Ventures Holdings Corp. I | 1 | Seeking Alpha | ||
| 19.09. | Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I | 112 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today announced that it has provided notice to Achari Ventures Holdings Corp. I ("Achari") to terminate... ► Artikel lesen | |
| 19.09. | VASO Corp - 8-K, Current Report | - | SEC Filings | ||
| 10.09. | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 26.08. | Vaso Corporation Announces Date Change for Its Stockholders Meeting | 1 | GlobeNewswire (USA) | ||
| 23.08. | Vaso Corp announces pro forma financials amid business combination | 1 | Investing.com | ||
| 23.08. | VASO Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 16.08. | VASO Q2 Earnings Flat Y/Y, Revenues Down, Gross Margin Contracts | 1 | Zacks | ||
| 15.08. | Vasomedical reports Q2 results | 1 | Seeking Alpha | ||
| 14.08. | VASO Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08. | Vaso Corporation Announces Financial Results for Second Quarter 2024 | 91 | GlobeNewswire (Europe) | High deferred revenue and backlog setting stage for 2024 revenue and income growth PLAINVIEW, N.Y., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating... ► Artikel lesen | |
| 07.08. | Vaso Corporation Announces the Effectiveness of the Achari Ventures Holdings Corp. I Registration Statement on Form S-4 | 1 | GlobeNewswire (USA) | ||
| 25.07. | Zacks Initiates Coverage of Vaso With Neutral Recommendation | 1 | Zacks | ||
| 15.05. | Vaso Corporation Announces Financial Results for First Quarter 2024 | 122 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. "Total revenue for the first... ► Artikel lesen | |
| 01.04. | Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2023 | 93 | GlobeNewswire (Europe) | PLAINVIEW, N.Y., April 01, 2024 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO) today announced its operating results for the three months and year ended December 31, 2023. "The Company... ► Artikel lesen | |
| 07.12.23 | Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger | 544 | ACCESSWIRE | Business Combination with Achari Ventures Holdings Corp. I is Expected to Be Completed in First Quarter of 2024Merger with Achari Ventures Holdings Corp. I (NASDAQ:AVHI) expected to improve capital... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 19,500 | -0,23 % | Bayer-Aktie: Kursziele fallen nach dem Absturz | Die Bayer-Aktie hat in dieser Woche nach den Quartalszahlen einen massiven Absturz erlebt. Doch mit dem Abverkauf scheint es kein Ende zu nehmen, zumal die Analysten aktuell negative Urteile über den... ► Artikel lesen | |
| ASTRAZENECA | 121,65 | +0,50 % | Ihre wichtigsten Termine: Heute: Zahlen von AstraZeneca & Land Securities sowie frische US-Konjunkturdaten | © Foto: Julian Stratenschulte - dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 8,342 | 0,00 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 31,690 | 0,00 % | Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 12-Month Low on Insider Selling | ||
| CSPC PHARMA | 0,620 | -2,18 % | M Stanley Cuts CSPC PHARMA TP to $6.6 w/ Lower EPS Forecasts | ||
| ACADIA PHARMACEUTICALS | 14,845 | -3,88 % | Acadia Pharmaceuticals Inc - On Nov 18, Co Involuntarily Terminates COO Brendan Teehan | ||
| SELLAS LIFE SCIENCES | 1,132 | -3,41 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update | - Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 - - Data from the Phase 2a Trial of SLS009 in Relapsed/Refractory... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 305,30 | +1,39 % | Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra | ||
| CATALYST PHARMACEUTICALS | 20,090 | +0,10 % | Vorstandsvorsitzender von Catalyst Pharmaceuticals verkauft Aktien im Wert von 3,1 Millionen US-Dollar | ||
| OPUS GENETICS | 0,949 | +2,48 % | Foundation Fighting Blindness: The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics | The resulting company will operate under the name Opus Genetics and the Nasdaq ticker symbol (IRD)
RALEIGH, N.C., Oct. 25, 2024 /PRNewswire/ -- The RD Fund (Retinal... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,058 | 0,00 % | ENZON PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | ||
| CHUGAI PHARMACEUTICAL | 39,350 | +1,26 % | Dividendenbekanntmachungen (27.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVENTURE INC JP3122380003 22 JPY 0,128 EUR AGC INC JP3112000009 105 JPY 0,6111 EUR ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0... ► Artikel lesen | |
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse | Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,140 | -2,78 % | VIRX stock touches 52-week low at $0.15 amid market challenges | ||
| SAVARA | 2,800 | -6,04 % | Savara-Direktor Joseph McCracken erwirbt Stammaktien im Wert von 59.071 US-Dollar |
Das Unternehmen VASO CORPORATION kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VASO CORPORATION finden Sie auf Wallstreet Online.
